ITDD helps effectively manage chronic pain and spasticity in some patients but requires adherence to best practices and a ...

Neuropathic pain affects more than 20 million people in the U.S., and at least a quarter of these cases are puzzling for ...

At present, the impact of the pharmacogenetics on the response to treatment in neuropathic pain is poorly known, but several polymorphisms, among them the cytochrome P450 (CYP)2D6, may intervene.

A recent study has raised concerns about the widespread prescription of antidepressants for chronic pain, warning that many ...

The National Comprehensive Cancer Network (NCCN)-;an alliance of leading cancer centers focusing on maintaining evidence-based expert consensus driven guidelines for care-;announces the publication of ...

a The three most commonly used maintenance doses are depicted. b Patients taking 25-50 mg once daily should take one supplemental pregabalin dose of 50 or 75 mg after hemodialysis. c Patients ...

Opioids have long been used to treat severe pain, though their use in the management of chronic pain remains somewhat controversial. Some people can tolerate opioids for years without any adverse ...

the general guidelines are to continue your normal activities as much as you can. Over-the-counter pain relievers and placing heat on the back (such as a heating pad) may help with relief. If it doesn ...

Operator Good day, and welcome to the Vertex Pharmaceuticals third quarter 2024 earnings call. All participants will be in a ...

Q3 2024 Earnings Call Transcript November 4, 2024 Vertex Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $4.38, expectations were $4.14. Operator: Good day. And welcome to ...

Each gummy contains 15 mg of delta 9 THC, 100 mg of CBD, and 5 mg of CBG. These come in an assorted mix of tropical and fruit ...

Dementia treatment is more than just medication ... interactions and touch could help relieve stress, agitation, and pain for people with dementia. Dementia isn’t just about changes to memory ...